Doctor-led medical care · Ubi, Singapore 6844 1528 WhatsApp

GLP-1 Explained

What Is Wegovy? A Doctor Explains the GLP-1 Weight-Loss Medication

Wegovy (semaglutide) explained by a doctor: how GLP-1 medicines work, what the research shows, side effects and questions to ask your doctor.

30 August 2026 · 8 min · Medically reviewed by Dr Joseph Wang

Unbranded GLP-1 weight-loss injection pen on a clinic counter

Medical information notice: This article is general health education, not medical advice, and does not promote any particular treatment. Whether any prescription medicine is appropriate for you can only be decided by a doctor who knows your health history. At the end of this article we explain how a medical assessment works at our clinic.

What is Wegovy?

Wegovy is the brand name for semaglutide 2.4 mg, a prescription medicine developed for chronic weight management in adults living with obesity or overweight with weight-related health conditions. It belongs to a class of medicines called GLP-1 receptor agonists — medicines that copy the action of a natural hormone involved in appetite regulation.

It is given as a once-weekly injection under the skin, using a pre-filled pen. The dose starts low and is increased gradually over several weeks, which is how doctors reduce digestive side effects while the body adjusts.

It is one of several GLP-1 medicines studied for weight management. “Brand name vs generic name” matters here: semaglutide is the ingredient; Wegovy is one branded product containing it. Understanding that distinction helps when comparing information online.

How GLP-1 medicines work

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases naturally after you eat. It has three main jobs:

  1. Appetite signalling — it acts on receptors in the brain’s appetite centres, increasing the feeling of fullness.
  2. Gastric emptying — it slows how quickly food leaves the stomach, so meals keep you satisfied for longer.
  3. Insulin support — it supports insulin release in a glucose-dependent way, which is why the same hormone pathway is also relevant in type 2 diabetes.

In many people with obesity, this hormone system doesn’t signal as strongly as it should — one reason why “just eat less” is biologically harder than it sounds. GLP-1 medicines restore a stronger fullness signal, which makes a sustained calorie deficit physiologically achievable rather than a daily act of willpower.

That is also why these medicines work best together with nutrition, activity and behavioural support — not instead of it.

What the research shows

The STEP trial programme (a series of large randomised controlled trials published in journals including the New England Journal of Medicine) studied semaglutide 2.4 mg for weight management:

  • Participants receiving the medicine plus lifestyle support lost on average around 10–15% of body weight over approximately 68 weeks, versus a few percent with lifestyle support alone.
  • Improvements were also seen in waist circumference, blood pressure, blood lipids and blood-sugar markers.
  • Weight regain after stopping was a documented challenge — reinforcing the need for a maintenance plan.

Trial results describe average groups under research conditions. Your individual result depends on your starting point, dose reached, genetics, diet quality, activity and follow-through. A doctor can give you a realistic, personalised estimate — no responsible clinician promises a number.

Who may be a candidate

International guidelines generally frame GLP-1 weight-management medicines for adults with:

  • BMI ≥ 30, or
  • BMI ≥ 27.5 with a weight-related condition (for example type 2 diabetes, high blood pressure, high cholesterol or sleep apnoea)

In Singapore, the Asian BMI thresholds are lower (overweight from 23, obesity from 27.5) because health risks appear at lower body weights in Asian populations — so the threshold conversation with your doctor may differ from American or European websites.

Suitability is always individual. A medical assessment reviews your history, medications, and conditions that could make this class of medicine unsuitable (for example certain thyroid, pancreas or pregnancy-related situations).

Side effects and safety

Most side effects are digestive and occur early:

  • Nausea (the most common)
  • Vomiting, diarrhoea or constipation
  • Usually improving as the dose increases gradually

Less common but important risks — including pancreatitis, gallbladder issues, and the thyroid concerns that led to boxed warnings for this medicine class — are exactly why a proper medical assessment and ongoing monitoring are part of legitimate treatment. A doctor screens for these before prescribing and reviews you throughout.

Red-flag symptoms (severe abdominal pain, persistent vomiting, signs of dehydration) always warrant contacting the clinic promptly.

Why medical supervision matters more than the medicine

The medicine is one part of a system. In a supervised programme:

  • Before starting: full history, medication review, BMI and body-composition measurement, realistic goal-setting.
  • During: gradual dose escalation, side-effect management, nutrition guidance (adequate protein matters), activity targets, and regular reviews.
  • After the target: a planned maintenance phase — because appetite signalling reverts when treatment stops, and the habits built during treatment are what protect the result.

This is also the honest answer to “why can’t I just buy it online”: without assessment, dosing and monitoring, both effectiveness and safety suffer — and counterfeit products are a real danger.

Questions to ask your doctor

If you are considering GLP-1 treatment, bring these questions to a consultation:

  1. Am I a candidate — and which approach fits my health history?
  2. What result can I realistically expect, over what timeline?
  3. What side effects should I expect, and how are they managed?
  4. How long would I stay on treatment, and what happens afterwards?
  5. How is progress measured beyond the scale (waist, body composition, blood markers)?
  6. What does the full programme involve — reviews, diet support, activity plans?

How we approach weight management at Accord Medical

Our clinic runs a doctor-led weight management programme in Ubi, Singapore: a full medical assessment first, then a personalised plan that may include prescription options where appropriate, alongside nutrition coaching, activity targets and body-composition tracking (InBody). Follow-ups are with the same doctor, evenings and weekends included.

If you would like to discuss whether medical weight management is right for you, you can book a consultation through our website, message us on WhatsApp, or call the clinic — the doctor will assess your situation honestly, including if a non-medication path is the better first step.

Last reviewed by Dr Joseph Wang, Family Physician.

Frequently asked questions

Is Wegovy the same as Ozempic?

Both contain the same active ingredient (semaglutide) but are different products at different doses, approved for different purposes. Wegovy is specifically approved at higher doses for chronic weight management, while Ozempic is approved for type 2 diabetes. A doctor determines which, if any, option is appropriate for you.

How does Wegovy reduce appetite?

It mimics GLP-1, a natural gut hormone released after meals. GLP-1 acts on appetite centres in the brain, increases the feeling of fullness, and slows stomach emptying — so you feel satisfied with smaller amounts of food.

How much weight do people lose?

In the STEP clinical trial programme, participants combining a GLP-1 medicine with lifestyle support lost around 10–15% of body weight on average over about 68 weeks. Individual results vary widely — genetics, dose, diet, activity and follow-through all matter. Your doctor can estimate what is realistic for you.

What are the most common side effects?

Digestive effects are the most common: nausea, vomiting, diarrhoea or constipation, mostly in the first weeks while the dose is gradually increased. They usually settle with time. Rarer risks are discussed and screened for in a proper medical assessment.

Do I have to stay on it forever?

Obesity is a chronic condition, and appetite hormones return towards pre-treatment levels when the medicine stops — which is why weight regain is common without a maintenance plan. A supervised programme plans the transition: sustainable eating patterns, activity, and follow-up reviews.

Can I get Wegovy without a prescription?

No. It is a prescription-only medicine and should never be bought online or from unverified sources. A doctor must assess your health history, check for conditions that make it unsuitable, prescribe the right dose escalation, and monitor you while you take it.

WhatsApp